license: cc-by-nc-4.0
task_categories:
- tabular-classification
- tabular-regression
language:
- en
tags:
- synthetic
- healthcare
- genomics
- variant-calling
- vcf
- vep
- cadd
- clinvar
- gnomad
- rna-seq
- bulk-rna-seq
- single-cell
- scrna-seq
- pbmc
- gene-expression
- polygenic-risk-score
- prs
- pharmacogenomics
- pgx
- cpic
- pharmgkb
- cyp2d6
- cyp2c19
- ancestry
- grch38
- hg38
- titv
- hardy-weinberg
- tabula-sapiens
- gtex
- 10x-genomics
pretty_name: HLT-013 Synthetic Multi-Modal Genomics Dataset (Sample Preview)
size_categories:
- 1K<n<10K
HLT-013 — Synthetic Multi-Modal Genomics Dataset (Sample Preview)
A free, schema-identical preview of the full HLT-013 commercial product from XpertSystems.ai.
A fully synthetic multi-modal genomics dataset combining variant calls (VCF-style with VEP/CADD/ClinVar/gnomAD annotations), bulk RNA-seq gene expression (5 tissues × 2,000 genes), single-cell RNA-seq PBMC profiles (10 cell types), polygenic risk scores (50 traits across 5 disease domains), and pharmacogenomics star allele calls (25 CPIC-actionable genes) — all linked through 1,000 individuals across 5 ancestry superpopulations (EUR/AFR/EAS/AMR/SAS, gnomAD-calibrated).
⚠️ PRIVACY & SYNTHETIC NATURE Every record in this dataset is 100% synthetic. No real patient data, no PHI, no real genome sequences, no real variant calls. Population-level distributions match published gnomAD / ClinVar / VEP / CPIC / Tabula Sapiens benchmarks but the genomic profiles are computationally generated.
What's in this sample
1,000 individuals × 6 multi-modal genomic data tables linked by sample_id.
| File | Rows × Cols | Description |
|---|---|---|
cohort_manifest.csv |
1,000 × 10 | Individual master — ancestry, sex, age, sequencing type, mean coverage, pct bases ≥20x, consent tier |
variants_annotated.csv |
600 × 14 | VCF-style: CHROM/POS/RSID/REF/ALT/GT/GQ/DP + VEP consequence + CADD Phred + ClinVar sig + gnomAD AF + HWE p-value |
gene_expression.csv |
2,000 × 7 | Bulk RNA-seq gene panel — mean log2TPM, SD, CV, % expressed, housekeeping flag |
scrna_pbmc.csv |
~1,900 × 11 | Single-cell PBMC: cell type, cluster ID, UMAP coords, n_genes, n_counts, pct_mito, doublet score |
polygenic_risk_scores.csv |
1,000 × 152 | 50 PRS traits × (raw score + ancestry-adjusted percentile + risk tier) per individual |
pharmacogenomics.csv |
1,000 × 102 | 25 PGx genes × (star allele class + CPIC recommendation + ACMG actionable + drug-specific guidance) |
metadata.json |
— | Run manifest: seed, genome build, ancestry distribution, Ti/Tv, tissue/cell-type/PRS/PGx counts |
Total: ~2.4 MB across 8 files.
Schema highlights
cohort_manifest.csv (10 columns)
sample_id, ancestry_superpop (EUR/AFR/EAS/AMR/SAS), sex, age, cohort_id, genome_build (GRCh38), sequencing_type (WGS/WES), mean_coverage (numeric, 30x WGS / 100x WES mix), pct_bases_20x (QC metric), consent_tier (research/clinical/broad)
variants_annotated.csv (14 columns)
Position: CHROM (1-22, X), POS (genomic coordinate), RSID (rs identifier), REF, ALT, variant_type (SNP/InDel)
Genotype: GT (0/0, 0/1, 1/1), GQ (genotype quality 0-99), DP (read depth)
Annotation: consequence (VEP terms: intergenic / intron / synonymous / missense / 3'UTR / 5'UTR / splice_region / stop_gained / splice_donor / splice_acceptor / frameshift / inframe_indel), CADD_phred (deleteriousness 0-50+), ClinVar_sig (Benign / Likely_benign / VUS / Likely_pathogenic / Pathogenic), AF_gnomAD (allele frequency 0-1)
Population genetics: HWE_pval (Hardy-Weinberg Equilibrium p-value)
gene_expression.csv (7 columns)
gene_id (ENSG-style), gene_name, mean_log2TPM, sd_log2TPM, cv (coefficient of variation), pct_expressed (% of individuals with detectable expression), is_housekeeping (flag for stably-expressed reference genes)
scrna_pbmc.csv (11 columns)
sample_id, cell_barcode, cell_type (10 types: CD4_T_naive, CD4_T_memory, CD8_T_cytotoxic, B_cell_naive, B_cell_memory, NK_cell, Monocyte_classical, Monocyte_nonclassical, pDC, Platelet), cluster_id, UMAP_1, UMAP_2, n_genes, n_counts, pct_mito, doublet_score, cell_type_confidence
polygenic_risk_scores.csv (152 columns)
sample_id, ancestry, plus 50 traits × 3 fields each:
PRS_<trait>— raw polygenic scorePRS_<trait>_pct— ancestry-adjusted percentile (0-100)PRS_<trait>_tier— risk tier (Low/Intermediate/High)
50 traits across 5 domains:
- CVD (10): coronary_artery_disease, atrial_fibrillation, heart_failure, hypertension, stroke, peripheral_artery_disease, abdominal_aortic_aneurysm, hypertrophic_cardiomyopathy, dilated_cardiomyopathy, long_qt_syndrome
- Metabolic (10): type2_diabetes, BMI, LDL_cholesterol, HDL_cholesterol, triglycerides, fasting_glucose, HbA1c, type1_diabetes, obesity, NAFLD
- Oncology (10): breast_cancer, prostate_cancer, colorectal_cancer, lung_cancer, melanoma, ovarian_cancer, pancreatic_cancer, glioma, leukemia, lymphoma
- Autoimmune (10): rheumatoid_arthritis, type1_diabetes_autoimmune, MS, lupus, psoriasis, IBD_crohns, IBD_ulcerative_colitis, celiac, asthma, atopic_dermatitis
- Psychiatric (10): depression, bipolar, schizophrenia, anxiety, ADHD, autism, alzheimers, parkinsons, alcohol_dependence, smoking_behavior
pharmacogenomics.csv (102 columns)
sample_id, ancestry, plus 25 genes × 4 fields each:
PGx_<gene>_class— predicted phenotype (NM=Normal Metabolizer / IM=Intermediate / PM=Poor / RM=Rapid / UM=Ultrarapid)PGx_<gene>_CPIC— CPIC dosing recommendation (Standard/Reduce/Increase/Avoid)PGx_<gene>_ACMG_actionable— ACMG SF v3.2 actionable flagPGx_<gene>_recommendation— drug-specific guidance text
25 genes (CPIC Level A or B): CYP2D6, CYP2C19, CYP2C9, CYP3A5, CYP2B6, CYP1A2, TPMT, NUDT15, DPYD, SLCO1B1, VKORC1, UGT1A1, HLA-B, HLA-A, CYP4F2, IFNL3, G6PD, RYR1, CACNA1S, ABCG2, F5, MTHFR, NAT2, ATM, BRCA1
Calibration source story
The full HLT-013 generator anchors all distributions to authoritative genomics references:
- gnomAD v4 (Karczewski et al. 2020) — Population allele frequencies, ancestry superpopulation proportions
- VEP (McLaren et al. 2016) — Variant Effect Predictor consequence annotation
- ClinVar (Landrum et al. 2018) — Clinical variant significance database
- CADD (Rentzsch et al. 2019) — Combined Annotation Dependent Depletion scores
- CPIC — Clinical Pharmacogenetics Implementation Consortium dosing guidelines
- PharmGKB — Gene-drug interaction knowledge base
- 10x Genomics PBMC 10k reference — Single-cell PBMC cell type proportions
- Tabula Sapiens (Quake Lab) — Cross-tissue cell type catalog
- GTEx Consortium — Tissue-specific gene expression
- PGS Catalog (Lambert et al. 2021) — Polygenic score trait coverage
- ACMG SF v3.2 — Secondary findings actionable variant list
Sample-scale validation scorecard
| Metric | Observed | Target | Status | Source |
|---|---|---|---|---|
| EUR ancestry share | 40.2% | 40% ± 5% | ✅ PASS | gnomAD v4 |
| Ancestry superpop count | 5 | 5 | ✅ PASS | gnomAD |
| Ti/Tv ratio | 2.31 | 2.06 ± 0.80 | ✅ PASS | Wang et al. (2015) |
| ClinVar P/LP rate | 2.3% | 2.5% ± 2.5% | ✅ PASS | ClinVar |
| Mean coverage | 42.1x | 42 ± 10 | ✅ PASS | Clinical genomics QC |
| Cell type diversity | 10 | 10 | ✅ PASS | 10x Genomics PBMC 10k |
| PRS trait count | 50 | 50 | ✅ PASS | PGS Catalog |
| PGx gene count | 25 | 25 | ✅ PASS | CPIC Level A/B |
| CYP2D6 NM rate | 66.7% | 65% ± 15% | ✅ PASS | CPIC + PharmGKB |
| Expression tissue count | 5 | 5 | ✅ PASS | Tabula Sapiens / GTEx |
Grade: A+ (100/100) — verified across 6 random seeds (42, 7, 123, 2024, 99, 1).
Loading examples
Pandas — explore the cohort
import pandas as pd
cohort = pd.read_csv("cohort_manifest.csv")
variants = pd.read_csv("variants_annotated.csv")
prs = pd.read_csv("polygenic_risk_scores.csv")
pgx = pd.read_csv("pharmacogenomics.csv")
# Ancestry distribution
print(cohort["ancestry_superpop"].value_counts(normalize=True).round(3))
# Variant consequence breakdown
print(variants["consequence"].value_counts(normalize=True).round(3))
# ClinVar significance
print(variants["ClinVar_sig"].value_counts())
Variant filtering
import pandas as pd
variants = pd.read_csv("variants_annotated.csv")
# High-impact variants (Pathogenic + CADD > 25)
high_impact = variants[
(variants["ClinVar_sig"].isin(["Pathogenic", "Likely_pathogenic"])) |
(variants["CADD_phred"] > 25)
]
print(f"High-impact variants: {len(high_impact)}")
# Rare variants (gnomAD AF < 1%)
rare = variants[variants["AF_gnomAD"] < 0.01]
print(f"Rare variants: {len(rare)}")
# HWE-departure variants
hwe_violations = variants[variants["HWE_pval"] < 0.001]
print(f"HWE violations: {len(hwe_violations)}")
PRS risk stratification
import pandas as pd
prs = pd.read_csv("polygenic_risk_scores.csv")
# Top 10% CAD risk individuals
high_cad = prs[prs["PRS_coronary_artery_disease_pct"] >= 90]
print(f"High CAD risk: {len(high_cad)} individuals")
# Multi-trait risk profile
risk_traits = ["coronary_artery_disease", "type2_diabetes", "breast_cancer"]
for trait in risk_traits:
tier_col = f"PRS_{trait}_tier"
if tier_col in prs.columns:
print(f"\n{trait} risk tier distribution:")
print(prs[tier_col].value_counts(normalize=True).round(3))
PGx phenotype distribution
import pandas as pd
pgx = pd.read_csv("pharmacogenomics.csv")
# CYP2D6 phenotype by ancestry
print(pd.crosstab(pgx["ancestry"], pgx["PGx_CYP2D6_class"], normalize="index").round(3))
# Actionable findings (ACMG SF v3.2)
actionable_cols = [c for c in pgx.columns if c.endswith("_ACMG_actionable")]
n_actionable = pgx[actionable_cols].sum(axis=1)
print(f"\nIndividuals with ≥1 actionable PGx finding:")
print(f" None: {(n_actionable == 0).sum()}")
print(f" 1 gene: {(n_actionable == 1).sum()}")
print(f" 2+ genes: {(n_actionable >= 2).sum()}")
scRNA-seq cell type analysis
import pandas as pd
scrna = pd.read_csv("scrna_pbmc.csv")
# Cell type proportions per sample
cell_pcts = scrna.groupby("sample_id")["cell_type"].value_counts(normalize=True).unstack(fill_value=0)
print("Mean cell type proportions:")
print(cell_pcts.mean().sort_values(ascending=False).round(3))
# QC metrics by cell type
print("\nQC metrics by cell type:")
print(scrna.groupby("cell_type")[["n_genes", "pct_mito", "doublet_score"]].mean().round(2))
Hugging Face Datasets
from datasets import load_dataset
ds = load_dataset("xpertsystems/hlt013-sample", data_files={
"cohort": "cohort_manifest.csv",
"variants": "variants_annotated.csv",
"expression": "gene_expression.csv",
"scrna": "scrna_pbmc.csv",
"prs": "polygenic_risk_scores.csv",
"pgx": "pharmacogenomics.csv",
})
print(ds)
Suggested use cases
- Variant prioritization ML — train classifiers on CADD + ClinVar + AF features to predict pathogenicity
- PRS-disease prediction modeling — multi-trait ML for absolute risk stratification
- Ancestry imputation — train ancestry callers from variant features
- Variant Effect Predictor pipeline testing — schema-compliant data for VEP/SnpEff annotation pipeline development
- Pharmacogenomic CDS rules engine testing — populate PGx clinical decision support systems
- scRNA-seq cell type classification — train cell type callers from gene expression + UMAP coordinates
- HWE violation detection — flag spurious genotype calls or population structure
- Multi-modal genomics integration — joint modeling across variants + expression + PRS + PGx
- Clinical genomics LIMS testing — populate clinical genomics pipelines with realistic synthetic patients
- Healthcare AI pretraining — pretrain models on synthetic genomic profiles before fine-tuning on real biobank data
- Educational use — graduate genomics, biostatistics, and precision medicine coursework
Sample vs. full product
| Aspect | This sample | Full HLT-013 product |
|---|---|---|
| Individuals | 1,000 | 100,000+ (default) up to 1M |
| Variants per individual | 600 representative | Full WGS ~6.5M variants |
| Genes (bulk expression) | 2,000 | Full transcriptome ~20,000 genes |
| scRNA cells per sample | ~2 (sampled) | ~200 cells per sample |
| PRS traits | 50 | 50 (full coverage) |
| PGx genes | 25 | 25 (full CPIC Level A/B coverage) |
| Schema | identical | identical |
| Calibration | identical | identical |
| License | CC-BY-NC-4.0 | Commercial license |
The full product unlocks:
- Up to 1M individuals for biobank-scale genomic ML training
- Full WGS variant calls (~6.5M variants per individual)
- Full transcriptome (20,000+ genes)
- Dense scRNA-seq profiles (200+ cells per sample)
- GWAS summary statistics for the 50 PRS traits
- Family pedigrees for trio/quartet analysis
- Commercial use rights
Contact us for the full product.
Limitations & honest disclosures
- Sample is preview-only. 1,000 individuals × 600 representative variants is enough to demonstrate schema and calibration, but is not statistically sufficient for serious GWAS, PRS development, or rare variant analysis. Use the full product (100K+) for serious work.
- Variant set is sub-sampled. Each individual carries 600 representative variants (mix of SNPs + InDels), not the ~6.5M variants from full WGS. Variant positions are real-coordinate-valid but sparse.
- scRNA-seq cells per sample are sparse (~2 cells/sample at preview scale). Real PBMC scRNA-seq experiments yield 200-1000 cells per sample. The sample compresses this for size — full product has dense per-sample profiles.
- Gene expression is panel-summary, not per-individual. The
gene_expression.csvfile gives population-level summary statistics (mean log2TPM, SD, CV) across the 1,000 individuals, NOT individual-specific TPM values. For per-individual expression matrices, use the full product. - Housekeeping gene flag rate runs slightly high (~7.5% vs typical 1-3%). The generator marks more genes as housekeeping than strict biological definitions. Cross-reference with HK genes lists (Eisenberg & Levanon 2013) if exact housekeeping calls matter.
- Ti/Tv ratio variance is high at 600-variant sample scale (1.78-2.68 across seeds vs target 2.06). This is small-sample noise — full WGS at 6.5M variants converges tightly to the gnomAD target.
- RSIDs are synthetic. Generated RSIDs follow the rsXXXXXXX format but do NOT correspond to real dbSNP entries.
- gnomAD AF values are sampled from realistic distributions but are NOT real allele frequencies. Do not use this data for variant frequency reporting.
- ClinVar IDs not included. Variants have
ClinVar_sigclassifications but no real ClinVar variation IDs. - PRS scores are simulated, not based on real GWAS effect sizes. Distributions match published PRS percentile shapes but specific scores do NOT reflect real allele effects.
- PGx phenotype calls follow CPIC frequency distributions but are NOT mechanistic. Star allele class assignments are population-frequency-driven, not derived from underlying CYP/TPMT/etc. variant calls in
variants_annotated.csv. - Synthetic, not derived from real biobank data. Distributions match published gnomAD/ClinVar/CPIC/Tabula Sapiens references but do NOT reflect any specific real cohort (UK Biobank, All of Us, etc.).
Ethical use guidance
This dataset is designed for:
- Genomic ML methodology development
- Clinical genomics pipeline testing
- PRS modeling research
- Pharmacogenomics CDS rule engine development
- scRNA-seq cell type annotation methodology
- Healthcare AI pretraining for genomic prediction tasks
- Educational use in clinical genomics, precision medicine, and biostatistics
This dataset is not appropriate for:
- Making clinical genetic diagnoses about real individuals
- Real PRS reporting for real patients without validated ancestry-matched reference panels
- Pharmacogenomic prescribing decisions for real patients without CPIC consultation
- Variant pathogenicity calls without ACMG framework validation on real ClinVar data
- Ancestry-based discriminatory modeling
- Population-genetic claims about real ethnic groups
Companion datasets in the Healthcare vertical
- HLT-001 — Synthetic Patient Population (CDC/NHANES)
- HLT-002 — Synthetic EHR (FHIR R4)
- HLT-003 — Synthetic Clinical Trial
- HLT-004 — Synthetic Disease Progression
- HLT-005 — Synthetic Hospital Admission
- HLT-006 — Synthetic Medical Imaging
- HLT-007 — Synthetic Drug Response
- HLT-008 — Synthetic Healthcare Claims
- HLT-009 — Synthetic ICU Vital Sign Monitoring
- HLT-010 — Synthetic Hospital Resource Usage
- HLT-011 — Synthetic Rare Disease + Trial Eligibility
- HLT-012 — Synthetic Pandemic Spread
- HLT-013 — Synthetic Multi-Modal Genomics (you are here)
Use HLT-001 through HLT-013 together for the full healthcare data stack — and HLT-013 specifically extends the catalog into precision medicine & clinical genomics, complementing HLT-007 (drug response with PGx hooks) and HLT-011 (rare disease with gene-variant calls).
Citation
If you use this dataset, please cite:
@dataset{xpertsystems_hlt013_sample_2026,
author = {XpertSystems.ai},
title = {HLT-013 Synthetic Multi-Modal Genomics Dataset (Sample Preview)},
year = 2026,
publisher = {Hugging Face},
url = {https://huggingface.co/datasets/xpertsystems/hlt013-sample}
}
Contact
- Web: https://xpertsystems.ai
- Email: pradeep@xpertsystems.ai
- Full product catalog: Cybersecurity, Insurance & Risk, Materials & Energy, Oil & Gas, Healthcare, and more
Sample License: CC-BY-NC-4.0 (Creative Commons Attribution-NonCommercial 4.0) Full product License: Commercial — please contact for pricing.